The current report provides detailed exposure to the hematology analyzer market. This report highlights the current and future market potential of hematology analyzers, along with a detailed analysis of the drivers and challenges in the market. The report also covers market projections through 2028 and market rank for key players. It covers the competitive environment, regulatory scenario and outlines market share based on product/service and end user. Products/services include Instruments, Reagents and Consumables and Services. The market end users are hospitals and clinics, diagnostic centers, research institutes and other end users. This report includes company profiles of key players with detailed information on business segments, financials, product portfolios and recent developments. The report examines the impact of the COVID-19 pandemic on this market.
By geographical region, the market is segmented into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S. and Canada; Europe includes Germany, the UK, Italy, France, and the Rest of Europe; Asia-Pacific includes China, India, Japan and the Rest of Asia-Pacific. For market estimates, data has been provided for 2020 and 2021 as historical years, 2022 as the base year and forecasts have been made through 2028.
By geographical region, the market is segmented into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S. and Canada; Europe includes Germany, the UK, Italy, France, and the Rest of Europe; Asia-Pacific includes China, India, Japan and the Rest of Asia-Pacific. For market estimates, data has been provided for 2020 and 2021 as historical years, 2022 as the base year and forecasts have been made through 2028.
Report Includes
- 19 data tables and 45 additional tables
- An overview of global market outlook for hematology analyzers
- Analyses of global market trends, with data from 2020-2023 and projections of compound annual growth rates (CAGRs) through 2028
- Identification of market trends, issues and forecast impacting the global hematology analyzers market and quantification of the market based on product/service, end user, and region
- Discussion on market drivers such as growing incidence of blood disorders, increased preference for automated hematology instruments, and technological advancements in hematology analyzers
- Discussion on recent advancements and innovations available in the market
- Comprehensive company profiles of key players in the market, including Abbott, Boule Diagnostics AB, EKF Diagnostics Holdings Plc, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corp., and Nihon Kohden Corp.
Table of Contents
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Chapter 4 Market Dynamics
Chapter 5 Industry Overview
Chapter 6 Impact of the COVID-19 Pandemic
Chapter 7 Clinical Trial Analysis
Chapter 8 Patent Review
Chapter 9 Emerging Technologies in the Market
Chapter 10 Market Breakdown by Product/Service
Chapter 11 Market Breakdown by End User
Chapter 12 Market Breakdown by Region
Chapter 13 Competitive Landscape
Chapter 14 Company Profiles
List of Tables
List of Figures
Executive Summary
The global market for hematology analyzers was valued at $3.8 billion in 2022. The market is forecast to grow from $4.0 billion in 2023 at a compound annual growth rate (CAGR) of 5.7%, to reach approximately $5.3 billion by the end of 2028. This report segments the global market by product/service, end users and region.Reasons for Doing This Study:
Blood disorders affect a large population worldwide. Hematology analyzers diagnose and monitor blood disorders. The increasing prevalence of blood disorders and the growing adoption of these advanced automated hematology analyzers bring extensive opportunities to players in this market.Technological advancement is a critical factor in the hematology analyzer market. Hematology analyzers are fast, accurate, highly efficient and less labor intensive than manual blood cell-counting methods. This study will provide insights into upcoming trends in the hematology analyzer market.
Lastly, this report will provide a detailed analysis of key factors governing the growth of the hematology analyzer industry, providing strategic insights and recommendations for those looking to expand market share
Companies Mentioned
- Abbott
- Bio-Rad Laboratories, Inc.
- Boule Diagnostics Ab
- Danaher
- Diatron
- Ekf Diagnostics Holdings plc
- Horiba Ltd.
- Nihon Kohden Corp.
- Norma Instruments
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Siemens Healthineers AG
- Sysmex Corp.
- Transasia Bio-Medicals
- Trivitron Healthcare
- Wiener Laboratorios Saic
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 144 |
Published | June 2023 |
Forecast Period | 2023 - 2028 |
Estimated Market Value ( USD | $ 4 Billion |
Forecasted Market Value ( USD | $ 5.3 Billion |
Compound Annual Growth Rate | 5.7% |
Regions Covered | Global |
No. of Companies Mentioned | 15 |